TickerFactsScreenerDevelopers

Adaptive Biotechnologies Corp (ADPT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$34.86M2018: -$32.26M2019: $205.40M2020: -$149.68M2021: -$192.73M2022: -$183.94M2023: -$156.32M2024: -$95.21M2025: -$45.99M-$45.99M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$45.99M+51.7%
2024-$95.21M+39.1%
2023-$156.32M+15.0%
2022-$183.94M+4.6%
2021-$192.73M-28.8%
2020-$149.68M-172.9%
2019$205.40M+736.7%
2018-$32.26M+7.5%
2017-$34.86M—